Infectious diseases is one of the most critical threats to modern society. The objective of the project is the development of methods of non-invasive screening diagnostics of viruses and bacterial respiratory infections using laser spectroscopy and artificial intelligence (AI)methods.
Tasks of the project:
- The enhancement of artificial intelligence methods and the instrumental base of laser molecular spectroscopy.
- The development of methods of non-invasive screening diagnostics of viruses and bacterial respiratory infections on the basis of the spectral analysis of exhaled air using laser spectroscopy and artificial intelligence methods.
- The development of methods of non-invasive screening diagnostics of viruses and bacterial respiratory infections based on the spectral analysis of biological fluids using laser spectroscopy and artificial intelligence methods. The solution of the second and the third problem should include: the development of a protocol for experimental research; the selection of a group of patients with target diseases, the collection and the instrumental analysis of samples; the determination of informative features, the development and the validation of predictive models.
- The development of provocative tests for the assessment of the presence of viral respiratory infections on the mucosa of the oral cavity and and the bronchopulmonary system using laser spectroscopy.
Hosting organization
|
Field of studies
|
City
|
Invited researcher
|
Time span of the project
|
---|---|---|---|---|
Laboratory of Super-elastic Bio-interfaces
National Research Tomsk State University |
Medical biotechnologies |
Tomsk |
Volinsky Alexei
USA |
2021-2023 |
Laboratory of Clinical Smart Nano-technologies
I.M.Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University) |
Medical biotechnologies |
Moscow |
Liang Xing-Ji
China |
2021-2023 |
Laboratory of Molecular Allergology
Institute of Immunology of the Federal Biomedical Agency of Russia |
Medical biotechnologies |
Moscow |
Rudolf Valenta
Austria |
2018-2020 |